构建一个Nomogram模型,以估计在重症监护病房的老年患者中风扇相关肺炎的风险
Wensi Gan1,2, Zhihui Chen3, Zhen Tao4
1Department of Infection Control, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou 325001, China.
Advances in respiratory medicine
|February 23, 2024
概括
一种新的诺米图有效预测老年ICU患者的呼吸器相关肺炎 (VAP) 风险. 这种工具有助于对高风险个体的早期检测和干预,改善患者的治疗结果.
科学领域:
- 关键护理医学 关键护理医学
- 传染病流行病学 传染病流行病学
- 医疗信息学 医疗信息学
背景情况:
- 呼吸机相关肺炎 (VAP) 对老年重症监护室 (ICU) 患者构成重大风险,包括死亡率和长期住院.
- 目前缺乏准确的VAP风险评估工具,这阻碍了及时干预.
- 这项研究解决了对可靠方法的需求,以评估这种脆弱人群中的VAP风险.
研究的目的:
- 开发和验证用于预测老年ICU患者的VAP风险的诺米克图.
- 能够及早识别高风险个体,采取积极的保护措施.
- 加强临床决策和患者管理策略.
主要方法:
- 分析了293名老年ICU患者 (2016年1月至2021年3月) 的回顾性培训组和84名患者 (2021年4月至2022年2月) 的验证组.
- 最小绝对收缩和选择运算符 (LASSO) 和多变量后勤回归确定了关键预测因素.
- 构建了一个名图,并对校准,区分 (AUC 0.937/0.925) 和临床实用性 (DCA) 进行了验证.
主要成果:
- VAP风险的关键预测因素包括低蛋白血症,长时间使用抗生素,输管时间,机械通风时间和气管切除术.
- 在训练和验证队列中,名图显示出强大的预测性能,曲线下面积 (AUC) 值高.
- 校准和决策曲线分析证实了名图的准确性和临床适用性.
结论:
- 开发了一种新型名谱,可以准确预测老年ICU患者的VAP风险.
- 这种工具使医疗保健专业人员能够及早识别有风险的患者.
- 基于名谱预测的积极干预可以减轻VAP发生率并改善患者的治疗结果.
相关概念视频
Pneumonia III: Complications and Assessment
215
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
215
Pneumonia V: Nursing management and Prevention
2.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
Pneumonia I: Introduction
238
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
238
Assessment of Ventilation I: Respiratory Rate
1.1K
Assessment of Ventilation
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
1.1K
Pneumonia IV: Management
327
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
327
Acute Respiratory Failure-II
228
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
228


